Yunnan Botanee Bio-Technology Group Co

Yunnan Botanee Bio-Technology Group Co Current Liabilities

The Current Liabilities of Yunnan Botanee Bio-Technology Group Co (300957.SZ) as of Oct 31, 2026 is 490.34 M CNY. In the previous year, Current Liabilities was 1.53 B CNY — a change of -68.03% (lower).

Current Liabilities

490.34 MCNY

YoY

-68.03%

Last updated:

Current Liabilities of Yunnan Botanee Bio-Technology Group Co is 2025 490.34 M CNY. Current Liabilities of Yunnan Botanee Bio-Technology Group Co was 2024 1.53 B CNY. It decreases by -68.03% lower compared to the previous year.

The Yunnan Botanee Bio-Technology Group Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
333.63 M CNY
Jan 1, 2019
334.75 M CNY
Jan 1, 2020
453.24 M CNY
Jan 1, 2021
934.23 M CNY
Jan 1, 2022
1.05 B CNY
Jan 1, 2023
1.28 B CNY
Jan 1, 2024
1.53 B CNY
Jan 1, 2025
490.34 M CNY
The Yunnan Botanee Bio-Technology Group Co Current Liabilities history
YEARCurrent LiabilitiesYoY
490.34 MCNY-68.03%
1.53 BCNY+19.48%
1.28 BCNY+22.07%
1.05 BCNY+12.55%
934.23 MCNY+106.12%
453.24 MCNY+35.40%
334.75 MCNY+0.34%
333.63 MCNY+27.37%
261.93 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yunnan Botanee Bio-Technology Group Co Stock analysis

What does Yunnan Botanee Bio-Technology Group Co do? Yunnan Botanee Bio-Technology Group Co., Ltd. generates revenue through the research, development, manufacture, and sales of skin care products and services. The company's product portfolio includes creams, skin care lotions, facial masks, essences, lotions, and makeup items such as isolation creams, blemish balm (BB) creams, and makeup removers. Additionally, it offers medical device products like hyaluronic acid repairing biofilm and hyaluronic acid repairing dressings, designed for skin barrier protection post-minimally invasive surgery. Sales are driven by both offline and online channels, with the firm focusing on these distribution methods as key revenue streams. The company targets consumers seeking skincare solutions, particularly those requiring post-surgical skin care, through its medical device line. Its product range caters to a broad market segment, including daily skincare users and individuals needing specialized care for skin conditions. The firm's emphasis on both conventional skincare and medical-grade products allows it to address diverse consumer needs across multiple segments. Yunnan Botanee's revenue model relies on direct sales of its skincare and medical device products, with no mention of external partnerships or third-party branding. The company's focus on in-house R&D and manufacturing ensures control over product quality and pricing, supporting consistent revenue generation from its established customer base. Yunnan Botanee Bio-Technology Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yunnan Botanee Bio-Technology Group Co stock

Current Liabilities of Yunnan Botanee Bio-Technology Group Co is 490.34 M CNY in 2025.

Current Liabilities of Yunnan Botanee Bio-Technology Group Co changed from 1.53 B CNY to 490.34 M CNY, representing a -68.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Yunnan Botanee Bio-Technology Group Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Yunnan Botanee Bio-Technology Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Yunnan Botanee Bio-Technology Group Co

All Key Metrics — Yunnan Botanee Bio-Technology Group Co